MedPath

Modafinil

These highlights do not include all the information needed to use modafinil tablets safely and effectively. See full prescribing information for modafinil tablets. MODAFINIL tablets USP, for oral use, CIV Initial U.S. Approval: 1998

Approved
Approval ID

98e54b10-8ae0-7c43-e053-2a95a90ae8bb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 22, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Modafinil

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-5121
Application NumberANDA202566
Product Classification
M
Marketing Category
C73584
G
Generic Name
Modafinil
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 22, 2021
FDA Product Classification

INGREDIENTS (5)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
MODAFINILActive
Quantity: 100 mg in 1 1
Code: R3UK8X3U3D
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Modafinil - FDA Drug Approval Details